{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:00:35Z","timestamp":1789002035580,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2016R1D1A1A09919185"],"award-info":[{"award-number":["NRF-2016R1D1A1A09919185"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbrc.2018.02.188","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T12:55:02Z","timestamp":1519649702000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells"],"prefix":"10.1016","volume":"498","author":[{"given":"Seong Hyeok","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4685-2917","authenticated-orcid":false,"given":"In-Cheol","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.02.188_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.bbrc.2018.02.188_bib2","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin-resistance: past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2018.02.188_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2007.02.001","article-title":"Mechanisms of resistance to cisplatin and carboplatin","volume":"63","author":"Stewart","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3747\/co.2007.96","article-title":"Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea","volume":"14","author":"Maroun","year":"2007","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib6","first-page":"2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"Gramont","year":"2000","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1200\/JCO.2005.09.985","article-title":"Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology","volume":"23","author":"Jaanne","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib8","first-page":"8097","article-title":"GlutathioneS-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors","volume":"63","author":"Cullen","year":"2003","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib9","first-page":"295","article-title":"Effect of cisplatin-based chemotherapy on emergence of cisplatin resistance, and its correlation\u00a0with intracellular glutathione levels and accumulation of p53 protein in human ovarian cancer","volume":"15","author":"Juvekar","year":"2000","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bbrc.2018.02.188_bib10","first-page":"3087","article-title":"Loss of DNA mismatch repair in acquired resistance to cisplatin","volume":"56","author":"Aebi","year":"1996","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib11","first-page":"1862","article-title":"XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells","volume":"61","author":"Asselin","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib12","doi-asserted-by":"crossref","first-page":"20582","DOI":"10.1074\/jbc.M210992200","article-title":"The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair","volume":"278","author":"Hayakawa","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.02.188_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00280-004-0901-3","article-title":"Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine","volume":"55","author":"Fishel","year":"2005","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib14","first-page":"6559","article-title":"Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper","volume":"62","author":"Katano","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib15","first-page":"269","article-title":"Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine","volume":"1","author":"Scanlon","year":"1989","journal-title":"Canc. Commun."},{"key":"10.1016\/j.bbrc.2018.02.188_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0277-5379(90)90238-O","article-title":"Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil","volume":"26","author":"Kashani-Sabet","year":"1990","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.bbrc.2018.02.188_bib17","first-page":"2118","article-title":"Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-mxc","volume":"51","author":"Sklar","year":"1991","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib18","first-page":"75","article-title":"Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy","volume":"25","author":"Ren","year":"2010","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bbrc.2018.02.188_bib19","series-title":"Cisplatin Resistance: Molecular Basis of a Multifaceted Impediment","first-page":"283","article-title":"Cancer drug discovery and development: cancer drug resistance","author":"Siddik","year":"2006"},{"key":"10.1016\/j.bbrc.2018.02.188_bib20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/166949a0","article-title":"Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) link","volume":"166","author":"Cunningham","year":"1950","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.02.188_bib21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.lfs.2013.09.030","article-title":"Cordycepin: a bioactive metabolite with therapeutic potential","volume":"93","author":"Tuli","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2018.02.188_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00280-007-0467-y","article-title":"The role of Cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner","volume":"61","author":"Thomadaki","year":"2008","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib23","first-page":"6","article-title":"Downregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complex","author":"Goh","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.02.188_bib24","first-page":"93","article-title":"Circumvention of Cisplatin resistance in h-ras transformed-nih\/3t3 cells by suppressor mutant of h-ras","volume":"1","author":"Shinohara","year":"1992","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis","volume":"270","author":"Xia","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.02.188_bib26","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/MCB.19.8.5308","article-title":"B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK\/Erk pathway","volume":"19","author":"Erhardt","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1091\/mbc.11.3.1103","article-title":"The p42\/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal","volume":"11","author":"Le Gall","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2018.02.188_bib28","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/MCB.21.7.2324-2336.2001","article-title":"Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals","volume":"21","author":"von Gise","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/nen084","article-title":"Cordycepin induced MA-10 mouse Leydig tumor cell apoptosis through caspase-9 pathway","volume":"2011","author":"Jen","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bbrc.2018.02.188_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2184.2012.00814.x","article-title":"Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer","volume":"45","author":"Wen","year":"2012","journal-title":"Cell Prolif"},{"key":"10.1016\/j.bbrc.2018.02.188_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1023\/A:1020347732741","article-title":"Effect of hypoxia on Caspase-3, -8, and -9 activity and expression in the cerebral cortex of newborn Piglets","volume":"27","author":"Khurana","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00001813-200004000-00001","article-title":"Cisplatin resistance and oncogenes\u2014a review","volume":"11","author":"Dempke","year":"2000","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.bbrc.2018.02.188_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0006-2952(97)00101-9","article-title":"Modulation of cytotoxicity of chemotherapeutic drugsby activated H-ras","volume":"53","author":"Fan","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.02.188_bib34","first-page":"4682","article-title":"Ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.02.188_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2018.02.188_bib36","doi-asserted-by":"crossref","first-page":"50624","DOI":"10.1074\/jbc.M309011200","article-title":"Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells","volume":"278","author":"Park","year":"2003","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18304340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18304340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:23:41Z","timestamp":1757762621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18304340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0006291X18304340"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.188","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}